Effect of quantum dots on the biological behavior of the EJ human bladder urothelial carcinoma cell line

Yuan,Run; Yu,Wei‑Min; Cheng,Fan; Zhang,Xiao‑Bin; Ruan,Yuan; Cao,Zhi‑Xiu; Larré,Stéphane

doi:10.3892/mmr.2015.4174

Effect of quantum dots on the biological behavior of the EJ human bladder urothelial carcinoma cell line

Authors:
- Run Yuan
- Wei‑Min Yu
- Fan Cheng
- Xiao‑Bin Zhang
- Yuan Ruan
- Zhi‑Xiu Cao
- Stéphane Larré
View Affiliations

Affiliations: Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China
Published online on: August 3, 2015 https://doi.org/10.3892/mmr.2015.4174
Pages: 6157-6163

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Quantum dots (QDs) are a type of fluorescent label with applications in biological molecules, cells and in vivo imaging. The current study investigated the effect of QDs on the toxicity, proliferation, migration and invasion of the EJ human bladder cancer cell line in vitro. The cell counting kit‑8 test was used to measure the survival rate of EJ cells following incubation with varying concentrations of QDs. Additionally, the effect of QDs on tumor cell migration and invasion was evaluated using the Transwell chamber assay, and cell proliferation rate was assessed using a hemocytometer. Data from the current study demonstrated no significant differences in survival rate between the experimental and control groups with the conventionally used concentrations (5, 10 and 20 nM) of QD605 (P>0.05). However, with high concentrations of QD605 (40 and 80 nM), significant differences were observed (P<0.001). The survival rate of EJ cells, however, remained at 92.6%. In addition, no significant differences were observed between the EJ cells labeled with transactivator of transcription (TAT)‑QD605 and the unlabeled EJ cells with regard to proliferation, migration and invasion (P>0.05). Thus, the results of the current study indicate that QDs exhibit a certain degree of influence on the activity of the EJ bladder cancer cell line at high concentrations. However, at the concentrations that QDs are conventionally used, there was little impact on the survival of the EJ cells. In addition, the proliferation, migration and invasion abilities of the EJ cells were not affected by TAT‑QDs. Therefore, the peptide‑conjugated QDs have potential to be applied in the imaging and tracking of live cells in vitro and of animals in vivo. Notably, QDs may provide the foundation for a novel, non‑invasive imaging strategy for the early diagnosis of tumors.

View Figures

View References

1	Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
2	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA A Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
3	Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J and Rouprêt M; European Association of Urology (EAU): EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol. 59:997–1008. 2011. View Article : Google Scholar : PubMed/NCBI
4	Milowsky MI, Stadler WM and Bajorin DF: Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer. BJU Int. 102:1339–1344. 2008. View Article : Google Scholar : PubMed/NCBI
5	Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, et al: Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol. 19:666–675. 2001.PubMed/NCBI
6	Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, et al: Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: A contemporary series from the bladder cancer research consortium. J Urol. 176:2414–2422. 2006. View Article : Google Scholar : PubMed/NCBI
7	Yu RJ, Stein JP, Cai J, Miranda G, Groshen S and Skinner DG: Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy. J Urol. 176:493–498. 2006. View Article : Google Scholar : PubMed/NCBI
8	Nieder AM, Simon MA, Kim SS, Manoharan M and Soloway MS: Radical cystectomy after bacillus Calmette-Guérin for high-risk Ta, T1 and carcinoma in situ: Defining the risk of initial bladder preservation. Urology. 67:737–741. 2006. View Article : Google Scholar : PubMed/NCBI
9	Yu WW, Chang E, Drezek R and Colvin VL: Water-soluble quantum dots for biomedical applications. Biochem Biophys Res Commun. 348:781–786. 2006. View Article : Google Scholar : PubMed/NCBI
10	Larson DR, Zipfel WR, Williams RM, Clark SW, Bruchez MP, Wise FW and Webb WW: Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science. 300:1434–1436. 2003. View Article : Google Scholar : PubMed/NCBI
11	Akerman ME, Chan WC, Laakkonen P, Bhatia SN and Ruoslahti E: Nanocrystal targeting in vivo. Proc Natl Acad Sci USA. 99:12617–12621. 2002. View Article : Google Scholar : PubMed/NCBI
12	Algar WR, Tavares AJ and Krull UJ: Beyond labels: A review of the application of quantum dots as integrated components of assays, bioprobes, and biosensors utilizing optical transduction. Anal Chim Acta. 673:1–25. 2010. View Article : Google Scholar : PubMed/NCBI
13	Rosenthal SJ, Chang JC, Kovtun O, McBride JR and Tomlinson ID: Biocompatible quantum dots for biological applications. Chem Biol. 18:10–24. 2011. View Article : Google Scholar : PubMed/NCBI
14	Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS and Weiss S: Quantum dots for live cells, in vivo imaging, and diagnostics. Science. 307:538–544. 2005. View Article : Google Scholar : PubMed/NCBI
15	Geissler D, Charbonnière LJ, Ziessel RF, Butlin NG, Löhmannsröben HG and Hildebrandt N: Quantum dot biosensors for ultrasensitive multiplexed diagnostics. Angew Chem Int Ed Engl. 49:1396–1401. 2010. View Article : Google Scholar : PubMed/NCBI
16	Medintz IL, Uyeda HT, Goldman ER and Mattoussi H: Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater. 4:435–446. 2005. View Article : Google Scholar : PubMed/NCBI
17	Gao X, Cui Y, Levenson RM, Chung LW and Nie S: In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol. 22:969–976. 2004. View Article : Google Scholar : PubMed/NCBI
18	Smith AM, Ruan G, Rhyner MN and Nie S: Engineering luminescent quantum dots for in vivo molecular and cellular imaging. Ann Biomed Eng. 34:3–14. 2006. View Article : Google Scholar : PubMed/NCBI
19	Baiiey RE and Nie SM: Alloyed semiconductor guantum dots:Tuning the optical properties without changing the particle size. J Am Chem Soc. 125:7100–7106. 2003. View Article : Google Scholar
20	Han M, Gao X, Jack Z, Su JZ and Nie S: Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules. Nat Biotechnol. 19:631–635. 2001. View Article : Google Scholar : PubMed/NCBI
21	Wehrenberg BL, Wang CJ and Philippe GS: Interband and intraband optical studies of PbSe colloidal quantum dots. J Phys Chem B. 106:10634–10640. 2002. View Article : Google Scholar
22	Mattoussi H, Palui G and Na HB: Luminescent quantum dots as platforms for probing in vitro and in vivo biological processes. Adv Drug Deliv Rev. 64:138–166. 2012. View Article : Google Scholar
23	Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH and Libchaber A: In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science. 298:1759–1762. 2002. View Article : Google Scholar : PubMed/NCBI
24	Mattheakis LC, Dias JM, Choi YJ, Gong J, Bruchez MP, Liu J and Wang E: Optical coding of mammalian cells using semiconductor quantum dots. Anal Biochem. 327:200–208. 2004. View Article : Google Scholar : PubMed/NCBI
25	Pinaud F, King D, Moore HP and Weiss S: Bioactivation and cell targeting of semiconductor CdSe/ZnS nanocrystals with phytochelatin-related peptides. J Am Chem Soc. 126:6115–6123. 2004. View Article : Google Scholar : PubMed/NCBI
26	Jiang T, Zhang Z, Zhang Y, Lv H, Zhou J, Li C, Hou L and Zhang Q: Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery. Biomaterials. 33:9246–9258. 2012. View Article : Google Scholar : PubMed/NCBI
27	Milletti F: Cell-penetrating peptides: Classes, origin, and current landscape. Drug Discov Today. 17:850–860. 2012. View Article : Google Scholar : PubMed/NCBI
28	Nakase I, Tanaka G and Futaki S: Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells. Mol Biosyst. 9:855–861. 2013. View Article : Google Scholar : PubMed/NCBI
29	Cheng CJ and Saltzman WM: Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides. Biomaterials. 32:6194–6203. 2011. View Article : Google Scholar : PubMed/NCBI
30	Ezzat K, Zaghloul EM, El Andaloussi S, Lehto T, El-Sayed R, Magdy T, Smith CI and Langel U: Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions. J Control Release. 162:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
31	Bai H, You Y, Yan H, Meng J, Xue X, Hou Z, Zhou Y, Ma X, Sang G and Luo X: Antisense inhibition of gene expression and growth in gram–negative bacteria by cell-penetrating peptide conjugates of peptide nucleic acids targeted to rpoD gene. Biomaterials. 33:659–667. 2012. View Article : Google Scholar
32	Nakase I, Akita H, Kogure K, Gräslund A, Langel U, Harashima H and Futaki S: Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides. Acc Chem Res. 45:1132–1139. 2012. View Article : Google Scholar : PubMed/NCBI
33	Liu BR, Liou JS, Chen YJ, Huang YW and Lee HJ: Delivery of nucleic acids, proteins, and nanoparticles by arginine-rich cell-penetrating peptides in rotifers. Mar Biotechnol (NY). 15:584–595. 2013. View Article : Google Scholar
34	Liu BR, Huang YW and Lee HJ: Mechanistic studies of intracellular delivery of proteins by cell-penetrating peptides in cyanobacteria. BMC Microbiol. 13:572013. View Article : Google Scholar : PubMed/NCBI
35	Santra S, Yang H, Stanley JT, Holloway PH, Moudgil BM, Walter G and Mericle RA: Rapid and effective labeling of brain tissue using TAT-conjugated CdS: Mn/ZnS quantum dots. Chem Commun (Camb). 3144–3146. 2005. View Article : Google Scholar
36	Hyndman L, Lemoine JL, Huang L, Porteous DJ, Boyd AC and Nan X: HIV-1 Tat protein transduction domain peptide facilitates gene transfer in combination with Cationic liposomes. J Control Release. 99:435–444. 2004. View Article : Google Scholar : PubMed/NCBI
37	Chen B, Liu Q, Zhang Y, Xu L and Fang X: Transmembrane delivery of the cell-penetrating peptide conjugated semiconductor quantum dots. Langmuir. 24:11866–11871. 2008. View Article : Google Scholar : PubMed/NCBI
38	Lei Y, Tang H, Yao L, Yu R, Feng M and Zou B: Applications of mesenchymal stem cells labeled with Tat peptide conjugated quantum dots to cell tracking in mouse body. Bioconjug Chem. 19:421–427. 2008. View Article : Google Scholar
39	Xue FL, Chen JY, Guo J, Wang CC, Yang WL, Wang PN and Lu DR: Enhancement of intracellular delivery of CdTe quantum dots (QDs) to living cells by tat conjugation. J Fluoresc. 17:149–154. 2007. View Article : Google Scholar : PubMed/NCBI
40	Vives E, Schmidt J and Pèlegrin A: Cell-penetrating and cell-targeting peptides in drug delivery. Biochim Biophys Acta. 1786:126–138. 2008.PubMed/NCBI